Instil Bio Analyst Ratings
Instil Bio's Strategic Expansion and Pipeline Potential Bolster Buy Rating
H.C. Wainwright Maintains Instil Bio(TIL.US) With Buy Rating, Maintains Target Price $18
Analysts Are Bullish on These Healthcare Stocks: Instil Bio (TIL), Lexeo Therapeutics, Inc. (LXEO)
Instil Bio Analyst Ratings
Instil Bio Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Instil Bio (TIL) and Regeneron (REGN)
Instil Bio Analyst Ratings
Analysts' Top Healthcare Picks: Instil Bio (TIL), Evolus (EOLS)
Instil Bio Analyst Ratings
Instil Bio Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $2 Price Target
Instil Bio Analyst Ratings
Truist Financial Remains a Hold on Instil Bio (TIL)
HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $2 Price Target
Instil Bio Analyst Ratings
Analysts Are Bullish on Top Healthcare Stocks: Relay Therapeutics (RLAY), Instil Bio (TIL)
Instil Bio (TIL) Gets a Buy From H.C. Wainwright
HC Wainwright & Co. Initiates Coverage On Instil Bio With Buy Rating, Announces Price Target of $2
Analysts Offer Insights on Healthcare Companies: Instil Bio (TIL) and Regulus (RGLS)
No Data